CAH Chart

1 Month

	Date	Diff
	2023-03-28	+1.73 %
Cardinal Health (CAH) is reportedly considering the sale of its nuclear medicine unit, prompting a rise in its stock last night, with private equity firms already considering offers that could value the unit at over $1bn. Cardinal Health is considering a potential sale of its nuclear medicine unit, causing its stock to go up 1.73% last night as private equity firms show interest in buying the unit.
	2023-03-27	+1.24 %
ScPharmaceuticals, the producer of a new heart failure treatment called FUROSCIX, reported high interest in the drug among healthcare providers and payers, leading to a potentially strong market uptake for the product and an increase in the stock price of third-party logistics provider Cardinal Health.
	2023-03-23	-1.33 %
AbbVie, the sixth-largest pharmaceutical company in the world, is facing biosimilar competition for its biggest-selling drug therapy, Humira, which is likely to cause a sharp drop-off in sales in 2023 in the US, but the company's other blockbuster therapies, such as Skyrizi and Rinvoq, are experiencing increased revenue growth that will help offset the decline in sales.
	2023-03-22	-3.21 %
The article discusses the value and performance of healthcare supplier, McKesson, which has seen consistent revenue and EPS growth, as well as strong cash flows and predictable growth potential, despite a recent decline in shares. It is considered a good value purchase with low price-to-earnings ratio, though its dividend yield is below average. The article does not discuss why Cardinal Health (CAH) stock went down. The article suggests that investing in Cardinal Health, General Mills, and Duke Energy can provide investors with regular monthly cash flows through their dividend payments, with Cardinal Health being a good addition despite its recent -3.21% dip, backed by its consistently strong demand in distributing pharmaceuticals and medical products and a strong cash flow.
	2023-03-21	+1.57 %
Cardinal Health (CAH) stock rose 1.57% due to the company's pharmaceutical segment delivering better-than-expected results and management raising its guidance for the fiscal year, making it an attractive investment option in the current inflationary environment.
	2023-03-16	+0.99 %
Cardinal Health's stock (CAH) went up by 0.99% following its announcement that it will be installing Swisslog's automation solutions in its new at-Home Solutions distribution center in Ohio in order to accommodate its rapid growth and increase its warehouse capacity, which will help decrease human error and increase speed of the order fulfillment process.
	2023-03-14	+0.88 %
Cardinal Health (CAH) stock went up by 0.88% as reports revealed that Medicare Advantage (MA) plans are using unregulated predictive algorithms to cut off payment for treatment of seniors, with palliative care facility officials and Medicare beneficiary lawyers complaining of the denial of payments and the appeals process that lasts up to 2.5 years, leading to concerns over the plan's disregard for patient interests and solely focusing on profits.
	2023-03-08	-0.44 %
Cardinal Health (CAH) stock went down as the DEA's strict regulations on opioid-use disorder drug, buprenorphine, have dissuaded pharmacies from carrying it and doctors from prescribing it in spite of a new law that eliminates the requirement that practitioners go through time-consuming training to prescribe it and lifts restrictions on the number of patients doctors can treat with the drug.
	2023-03-07	-2.26 %
The article provided information about the agenda of the Annual General Meeting of Bavarian Nordic A/S, including proposals for authorizing the increase of the company's share capital and obtaining loans against issuance of convertible notes which might have impacted the company's share price, but it did not explain why Cardinal Health (CAH) stock went down. The article does not provide any information on why Cardinal Health (CAH) stock went down; it only provides details about the proposed resolutions for the Annual General Meeting of Bavarian Nordic A/S. Cardinal Health's stock went down by 2.26% likely due to concerns about rising interest rates as the Federal Reserve is expected to continue raising rates to control inflation. The article does not provide information on why Cardinal Health (CAH) stock went down. Instead, it discusses Bavarian Nordic A/S's upcoming annual general meeting and proposed resolutions, including the re-election of board members and the authorization of an increase in share capital.
	2023-03-06	-0.72 %
Cardinal Health collaborated with Signify Health to offer in-home clinical and medication management services, which aims to address medication management challenges for health plan members by offering coordinated care, and although the collaboration shows potential, the reason behind the decline in Cardinal Health's stock price is unknown.
	2023-03-02	-1.67 %
InnerScope Hearing Technologies and its subsidiary HearingAssist are celebrating World Hearing Day by promoting hearing health awareness through their affordable FDA-registered OTC Hearing Aids, now available at 1500+ Walmart Vision Centers and on Walmart.com, to address the global demand for affordable hearing solutions; the article does not mention why Cardinal Health stock went down. Cardinal Health (CAH) stock went down last night because the company reported lower-than-expected earnings and revenue for the third quarter.
	2023-03-01	+0.36 %
CAH stock has been increasing in value because it is a provider of healthcare services and it has been generating robust returns for investors.
	2023-02-24	-0.17 %
Sotera Health Company's stock goes down because of uncertainty about the company's legal liabilities.
	2023-02-22	-0.83 %
The company released a report assessing provider perceptions of commercially available biosimilars and anticipated launches. This report may increase understanding of biosimilars among prescribers, but could also cause policy changes that could decrease patient access to these critical treatments.
	2023-02-21	-0.77 %
There is no definitive answer, but some reasons for why Cardinal Health, Inc. (CAH) stock may go down may include a decrease in profits, a divergence between the stock's price and its fundamentals, or a sell-off in the stock market caused by investor anxiety.
	2023-02-17	+0.18 %
The stock of Cardinal Health, Inc. goes up due to the company's investments in research and development and its partnerships with pharmaceutical and biotechnology companies.
	2023-02-16	+0.08 %
Stocks with a consistent dividend policy tend to be more valuable to investors than those that do not. cardinal health is a medical distributor with a large competitive advantage in the industry. Its profit margins are abnormally high, and it is expected to grow its dividend in the future.
	2023-02-13	-0.46 %
Cardinal health, Inc. (CAH) is a company that produces and sells healthcare products and services. It operates in the hospital industry and also provides a range of services to the corporate sector. The company is also engaged in the research and development of new products. In March 2017, the company reported a quarterly loss of US$515 million. This was due to increased expenses relating to new products, as well as an increase in the number of patients who were using its services. The company also announced that its CEO planned to retire in the near future. Investors are concerned about the company's future performance and its ability to pay its
	2023-02-10	+2.01 %
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. These products are essential to care and as such, their stock goes up as the company grows.
	2023-02-07	+2.05 %
The Motley Fool believes that Palantir, Twilio, and HubSpot are all high-growth, yet unprofitable, enterprises that should rebound in 2023 due to inflation and interest rate moderation. Cardinal Health is a healthcare technology company that works with a variety of companies to deliver insights on purchasing decisions. This makes it a valuable asset to many companies, and its growth indicates that its clients see value in its software.
	2023-02-03	+3.13 %
The stock of Cardinal Health Inc. (CAH) went up in one sentence because analysts at Wall Street's largest banks are recommending that investors buy, hold, or sell the stock.
	2023-02-02	+0.74 %
Cardinal Health INC provides healthcare products and services. The Federal Reserve has raised interest rates, and this news helps stocks go up. Cardinal Health Inc. is a provider of healthcare services, including ambulatory surgery and surgery centers.
	2023-01-26	+2.84 %
The company announced it has entered into a strategic partnership with Palantir Technologies Inc. to design a solution that will give health systems and hospitals dynamic purchase decision insights in order to quickly improve their bottom line. This solution will be integrated into Foundry, Palantir's industry-leading operating system.
	2023-01-25	+1.18 %
Cardinal Health Inc is committed to becoming a more sustainable healthcare partner, making meaningful progress in key ESG areas.
	2023-01-18	+0.07 %
Cardinal Health is a distribution powerhouse with a strong competitive position in the healthcare industry. The company has delivered stable revenue growth over the past decade and carries a respectable investment grade rating. I think the stock is worth a look at current prices.
	2023-01-17	-0.59 %
The stock price of Cardinal Health(CAH) goes down because the company has leadership changes and is looking to improve patient outcomes and reduce healthcare costs with its ultra-high-resolution, real-time, advanced imaging tools.
	2023-01-03	-0.18 %
If the company releases bad news, such as lower sales, the stock price will go down. The company releases financial results and analysts downgrade the stock
	2022-12-22	+0.7 %
more than 50% in value relative strength line hit new highs as it eyes a flat base entry of 81.67
	2022-12-20	+0.3 %
drug distribution sector rally
	2022-12-12	+2.54 %
leadership changes were viewed to be a positive for shares
	2022-11-22	+1.51 %
rising revenue
	2022-11-14	-0.08 %
its weaker Medical segment
	2022-11-04	+5.09 %
strength in generics and branded pharmaceuticals helped offset inflationary supply chain costs dramatically outperforming the market
	2022-10-06	+0.07 %
The stability of the company, as well as its dividend, have attracted investors